News Releases

ARLINGTON, Va., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) a national physician enablement company, announced it has signed a definitive agreement to enter the state of Washington in partnership with Walla Walla Clinic, a multi-specialty practice with more than 50

Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join Board ARLINGTON, Va., July 31, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the election of David S. Wichmann and Pamela O. Kimmet to its Board of Directors, effective August 1,

ARLINGTON, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2023 before market open on Thursday, August 3, 2023.

Distinguished Healthcare Leader Adam Boehler to Join Board Incoming CEO Parth Mehrotra to Join Board Will Sherrill Resigns from Board ARLINGTON, Va,, June 29, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that Adam Boehler, founder and Managing Partner of Rubicon

ARLINGTON, Va., May 31, 2023 (GLOBE NEWSWIRE) --  Privia Health Group, Inc. (Nasdaq: PRVA), today announced that its management team plans to participate in the following investor conferences: Tuesday, June 6 th – 9:00 am ET – William Blair Growth Stock Conference Wednesday, June 7 th – 1:30 pm ET

 - Investors include Durable Capital Partners LP and Rubicon Founders LLC ARLINGTON, Va., May 04, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company, today announced the upsized pricing of an underwritten secondary offering

– Investors include Durable Capital Partners LP and Rubicon Founders LLC ARLINGTON, Va., May 04, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA), a technology-driven, national physician enablement company, today announced the pricing of an underwritten secondary offering

ARLINGTON, Va., May 04, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced the commencement of an underwritten secondary offering of 31,319,473 shares of common stock by certain selling stockholders. The Company will not receive any of the proceeds from the sale of

Practice Collections +17.3% compared to 1Q’22 Implemented Providers +10.3% compared to 1Q’22 Company Reiterated Full Year 2023 Guidance ARLINGTON, Va., May 04, 2023 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the first quarter ended March 31,

Current President and COO Parth Mehrotra Named CEO; Shawn Morris to Retire and Remain on Board of Directors ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (Nasdaq: PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the